Skip Navigation

Articles

NEWS

ARTICLES

RESEARCH


A photo of Bentley.
Research

New Drug Dramatically Improves Survival for Children with Common Type of Leukemia

December 09, 2024

A University of Oklahoma Health Sciences clinical trial studying whether a drug called blinatumomab, when given in conjunction with chemotherapy, would improve patients’ survival without the cancer returning will now be standard practice to give in combination with chemotherapy to children with standard-risk B-ALL, the most common childhood cancer.

Hakeem Shakir.
Research

OU Researcher Contributes to Study Published in Prestigious New England Journal of Medicine

November 26, 2024

OU College of Medicine is one of 39 trial sites nationwide that found embolization plus surgery reduces risk of brain bleed recurrence.

Karl Hansen, M.D., Ph.D..
Impact

Clinical Trial of Device Aims to Induce Ovulation in Women with Polycystic Ovary Syndrome

December 04, 2024

Physicians at the University of Oklahoma Health Sciences in Oklahoma City are leading a national clinical trial to help women with polycystic ovary syndrome (PCOS)-related infertility who want to become pregnant.

A group of surgeous.
Impact

OU Health Surgeons First in Oklahoma to Use ‘Glowing’ Imaging Agent for Lung Cancer Surgery

November 15, 2024

OU Health has become the first health system in Oklahoma to utilize an innovative new imaging agent that causes lung cancer cells to glow during surgery. This marks a significant advancement in lung cancer treatment for the state, with the potential to improve surgical outcomes and recovery times for patients.

CAMPUS AND COMMUNITY


BY DATE